A phase I clinical trial with TriMix-dendritic cells in advanced melanoma patients: evaluation of the anti-vaccine cellular immune response

An Van Nuffel, Daphné Benteyn, Carlo Heirman, Jurgen Corthals, Bart Neyns, Kris Thielemans, Aude Bonehill

Onderzoeksoutput: Other scientific journal contribution

Originele taal-2English
TijdschriftAnnual Meeting of the Association for Immunotherapy of Cancer “CIMT”, Mainz, Germany
StatusPublished - mei 2009

Citeer dit